Frontier Capital Management CO LLC Catalent, Inc. Transaction History

Frontier Capital Management CO LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$53.58 - $57.02 $567,680 - $604,126	10,595 New	10,595 $595,000
Q4 2023 Feb 14, 2024	SELL	$32.18 - $46.57 $3.78 Million - $5.47 Million	-117,474 Reduced 21.44%	430,331 $19.3 Million
Q3 2023 Nov 14, 2023	BUY	$44.2 - $50.2 $4.2 Million - $4.77 Million	94,987 Added 20.98%	547,805 $24.9 Million
Q2 2023 Aug 14, 2023	SELL	$31.86 - $67.26 $7.74 Million - $16.3 Million	-242,838 Reduced 34.91%	452,818 $19.6 Million
Q1 2023 May 15, 2023	BUY	$45.44 - $74.26 $11.4 Million - $18.7 Million	251,501 Added 56.62%	695,656 $45.7 Million
Q4 2022 Feb 14, 2023	BUY	$41.39 - $81.0 $18.4 Million - $36 Million	444,155 New	444,155 $20 Million

216

73.2M

477K

2.02M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Frontier Capital Management CO LLC with notifications on news.